Two Sigma Securities’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
Two Sigma Securities's NVS Position: Q2 2026 in Review
Two Sigma Securities opened a new position in Novartis (NVS) in Q2 2026: 3,246 shares worth $509K. The stake represents 0.04% of the portfolio and ranks #573 among its holdings. This is a return to the name: Two Sigma Securities previously reported a position in NVS as recently as Q2 2025.
Two Sigma Securities first reported a position in NVS in Q1 2017 and has held it in 18 quarters since. The position peaked at $10.7M in Q1 2018. 1,620 funds tracked by Wall St. Rank hold NVS as of Q2 2026.
- Two Sigma Securities held 3,246 shares of Novartis worth $509K as of Q2 2026.
- Novartis was a new Two Sigma Securities position in Q2 2026.
- Novartis made up 0.04% of Two Sigma Securities's portfolio in Q2 2026, its #573 holding.
- Two Sigma Securities first reported a position in Novartis in Q1 2017 and has held it in 18 quarters since.
- Two Sigma Securities's Novartis position peaked at $10.7M in Q1 2018.
- 1,620 funds tracked by Wall St. Rank held Novartis as of Q2 2026.
Based on Two Sigma Securities's 13F filing for Q2 2026, filed 14 Aug 2026.